Protagonist Therapeutics Stock (NASDAQ: PTGX) stock price, news, charts, stock research, profile.
Open | $37.08 |
Close | - |
Volume / Avg. | 47.91K / 889.47K |
Day Range | 36.62 - 37.83 |
52 Wk Range | 13.72 - 38.03 |
Market Cap | $2.15B |
P/E Ratio | 14.89 |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 65 |
Short Interest | 3.53% |
Days to Cover | 1.7 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Protagonist Therapeutics (NASDAQ:PTGX) through any online brokerage.
Other companies in Protagonist Therapeutics’s space includes: Syndax Pharmaceuticals (NASDAQ:SNDX), PTC Therapeutics (NASDAQ:PTCT), Agios Pharmaceuticals (NASDAQ:AGIO), Novavax (NASDAQ:NVAX) and CG Oncology (NASDAQ:CGON).
There is no analysis for Protagonist Therapeutics.
Protagonist Therapeutics has a consensus price target of $44.60.
The stock price for Protagonist Therapeutics (NASDAQ: PTGX) is $36.74 last updated Today at July 17, 2024 at 10:20 AM EDT.
There are no upcoming dividends for Protagonist Therapeutics.
Protagonist Therapeutics’s Q2 earnings are confirmed for Thursday, August 1, 2024.
There is no upcoming split for Protagonist Therapeutics.
Protagonist Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.